SUCCESSFUL TREATMENT OF LUPUS NEPHRITIS IN MRL-LPR LPR MICE BY INHIBITING ORNITHINE DECARBOXYLASE

被引:20
|
作者
GUNNIA, UB
AMENTA, PS
SEIBOLD, JR
THOMAS, TJ
机构
[1] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, CLIN RES CTR, NEW BRUNSWICK, NJ 08903 USA
[2] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT MED, DIV RHEUMATOL, NEW BRUNSWICK, NJ 08903 USA
[3] UNIV MED & DENT NEW JERSEY, ROBERT WOOD JOHNSON MED SCH, DEPT PATHOL, NEW BRUNSWICK, NJ 08903 USA
关键词
D O I
10.1038/ki.1991.111
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Ornithine decarboxylase (ODC) is a key enzyme in the biosynthesis of cellular polyamines, putrescine, spermidine and spermine. Difluoromethylornithine (DFMO) is an irreversible inhibitor of ODC and thereby depletes putrescine and spermidine levels in vivo and in vitro. Previous studies in lupus-prone MRL-lpr/lpr mice treated with 1% DFMO in drinking water have been associated with improved lifespan, and reduced anti-DNA antibody production, lymphadenopathy, and splenic polyamine levels. Since glomerulonephritis is a major cause of morbidity and mortality in lupus, we studied the effect of DFMO on renal histology of MRL-lpr/lpr mice. Female BALB/c and MRL-+/+ mice were used as controls. Dose response studies revealed that 1.5% DFMO in drinking water had maximum therapeutic efficacy and produced a significant 79% increase in the median lifespan of a group of 20 mice compared to an equal number of controls (P < 0.001). Renal histologic studies were performed on kidney sections from four to five mice each from DFMO-treated and untreated groups at 12, 16, 20, 24 and 29 weeks of age. Sections were read blinded to duration and treatment and scored by four major histologic criteria (glomerulonephritis, interstitial inflammation, perivascular inflammation, and vasculitis) and showed significant reduction in all these parameters in DFMO-treated mice when compared to age- and sex-matched untreated mice of the same strain. DFMO treatment had no significant effect on pulmonary histologic findings on these mice. DFMO treatment reduced ODC activity and polyamine concentrations in treated mice. Basal ODC activity of 24-week-old untreated and DFMO-treated MRL-lpr/lpr mice was 142 +/- 14 and 27 +/- 6 pmol CO2/mg protein/hr, respectively. Basal kidney ODC activity of normal BALB/c and MRL-+/+ mice was 78 +/- 14 and 93 +/- 21 pmol CO2/mg protein/hr, respectively and indicated a constitutively high level of ODC activity in lupus-prone MRL-lpr/lpr mice compared to other strains. These data suggest an important role of endogenous polyamines in the tissue injury of lupus and suggest novel approaches to therapy of lupus-related renal disease.
引用
收藏
页码:882 / 890
页数:9
相关论文
共 50 条
  • [31] CORRECTION OF AUTOIMMUNE-DISEASE IN FASTRANSGENIC MRL-LPR/LPR MICE
    MOUNTZ, JD
    WU, JG
    ZHANG, JJ
    HE, J
    ZHOU, T
    ARTHRITIS AND RHEUMATISM, 1993, 36 (05): : R16 - R16
  • [32] Involvement of mast cells in the development of lupus-like skin lesions on MRL-lpr/lpr mice
    Yoshimasu, T.
    Kanazawa, N.
    Li, H.
    Mikita, N.
    Furukawa, F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S18 - S18
  • [33] Nitric oxide as an inflammatory mediator in autoimmune MRL-lpr/lpr mice
    Weinberg, JB
    ENVIRONMENTAL HEALTH PERSPECTIVES, 1998, 106 : 1131 - 1137
  • [34] ALW peptide ameliorates lupus nephritis in MRL/lpr mice
    Wang, Huixia
    Lu, Mei
    Zhai, Siyue
    Wu, Kunyi
    Peng, Lingling
    Yang, Jie
    Xia, Yumin
    ARTHRITIS RESEARCH & THERAPY, 2019, 21 (01)
  • [35] ANALYSES OF BRONCHOALVEOLAR LAVAGE FLUID (BALF) IN MRL-LPR/LPR MICE
    TAKAISHI, M
    AWAYA, Y
    ISHIOKA, S
    HOZAWA, S
    OYAMA, T
    TAKAHASHI, K
    MAEDA, H
    YAMAKIDO, M
    AUTOIMMUNITY, 1991, 8 (03) : 183 - 186
  • [36] Autoreactive T helper cells in MRL-lpr/lpr mice.
    Okada, M
    Fujii, T
    Craft, J
    ARTHRITIS AND RHEUMATISM, 1996, 39 (09): : 5511 - 5511
  • [37] SPONTANEOUS TEMPOROMANDIBULAR-JOINT ARTHROPATHY IN MRL-LPR/LPR MICE
    HARALDSON, T
    JONSSON, R
    TARKOWSKI, A
    JOURNAL OF ORAL PATHOLOGY & MEDICINE, 1988, 17 (08) : 386 - 389
  • [38] IA-ANTIGEN EXPRESSION AND AUTOIMMUNITY IN MRL-LPR/LPR MICE
    ROSENBERG, YJ
    GOLDSMITH, PK
    OHARA, J
    STEINBERG, AD
    OHRINER, W
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1986, 475 : 251 - 266
  • [39] Effects of FTY720 in MRL-lpr/lpr mice: Therapeutic potential in systemic lupus erythematosus
    Okazaki, H
    Hirata, D
    Kamimura, T
    Sato, H
    Iwamoto, M
    Yoshio, T
    Masuyama, J
    Fujimura, A
    Kobayashi, E
    Kano, S
    Minota, S
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (04) : 707 - 716
  • [40] Fn14 Deficiency Ameliorates Neuropsychiatric Disease In MRL-Lpr/Lpr Lupus Prone Mice
    Wen, Jing
    Xia, Yumin
    Michaelson, Jennifer S.
    Burkly, Linda C.
    Gulinello, Maria
    Putterman, Chaim
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S219 - S219